TUE28-Venous Symposium
 
 
 

13:30 – 15:00, Main Arena 2

Join an international panel of Venous experts to review results and current indications for Venous Intervention.

With a live case, best practices sharing and interactive case discussions you will learn how to optimise patients outcomes in acute and post thrombotic venous disease.

2020 Vision for Venous Interventions: Where do we go from here?

Chairperson: Prof Marzia Lugli
Co-Chair
: Dr Olivier Hartung
Panel: Mr Stephen Black, Dr Michael Lichtenberg, Dr. Houman Jalaie

  • Introduction and learning objectives, Dr. Olivier Hartung
  • Post Thrombotic Disease: The relevance of long term follow up. Prof Marzia Lugli
  • Pathway for the accelerated treatment of Venous Leg Ulcers. Mr Stephen Black
  • The VICI VENOUS STENT: 24 month outcome data. Dr. Michael Lichtenberg

Panel Discussion

  • Pharmacomechanical CDT: the future of DVT treatment? Prof Gerard O’ Sullivan

Recorded Live Case from Galway

  • Classification guided outcomes in Chronic Venous Obstruction, Dr. Houman Jalaie
  • A case based panel discussion

Conclusion & Key takeaways, Prof Marzia Lugli

Learning Objectives:

  • Understand the use of the EKOS™ Endovascular System for the treatment of venous thrombo embolism disease in the setting of acute and chronic deep vein thrombosis to prevent post-thrombotic morbidity
  • How to achieve only 6% PTS in the treatment of acute DVT.
  • Treatment of Chronic DVT with EKOS™ showing real world experience
  • Effective Treatment for High Risk and Intermediate-High Risk Pulmonary Embolism Patients with Acoustic Pulse Thrombolysis™
 
WED29 - Venous Symposium

12:30 - 13:30, Global Expert Exchange Forum room

In this symposium, our International Experts will present, share and discuss how they achieve optimal and effective results improving their patients quality of life, in treating patients with Venous Thrombo embolic disease.

Achieving quality & predictable outcomes in treatment of VTE

Moderator: Prof. Nils Kucher

Panel: Prof. Mert Dumantepe, Prof. Stefan Stortecky

  • How I achieve only 6% PTS at 12 months - Prof. Nils Kucher
  • Reproducing ACCESS PTS Data in Everyday Clinical Practice – Prof. Mert Dumantepe
  • Effective Treatment for High Risk and Intermediate-High Risk Pulmonary Embolism Patients with Acoustic Pulse Thrombolysis: Data from Bern –Prof. Stefan Stortecky
Attending this simposium will allow you to:
  • Understand the use of the EKOS™ Endovascular System for the
    treatment of venous thrombo embolic disease in the setting
    of acute and chronic deep vein thrombosis to prevent postthrombotic
    morbidity.
  • How to achieve only 6% PTS in the treatment of acute DVT.
  • Treatment of Acute DVT and PTS with EKOS™ showing real world experience.
  • Effective Treatment for High Risk and Intermediate-High Risk Pulmonary Embolism Patients with Acoustic Pulse Thrombolysis™
 
 
WED 29 - Arterial SImposium

9:30 – 11:00, Main Arena 1

Join an international panel to review current and breaking data and its implication for an evidenced based decision making strategy for SFA treatment. What are the best options from the whole interventional drug eluting technology portfolio and in which
patients?

Drug Eluting Technologies for PAD: From fundamentals to future

Co-Moderators: Prof Dierk Scheinert and Prof. Thomas Zeller

Panel: Dr Ravish Sachar, Prof. Marianne Brodmann, Prof. Andrew Holden, Prof. Giovanni Torsello

  • Introduction and learning objectives, Prof. Thomas Zeller
  • Fundamentals of Drug Coated Balloons, Dr .Ravish Sachar
  • Lessons from Ranger SFA II, Prof. Dr. Marianne Brodmann
  • Lessons from COMPARE RCT., Prof. Dierk Scheinert

Live case from Leipzig

  • Fundamentals of Drug Eluting Stents, Prof. Andrew Holden
  • Lessons from IMPERIAL, Prof. Thomas Zeller
  • Future trials, Prof. Giovanni Torsello
  • Close and key takeaways, Prof. Dirk Scheinert
Attending this symposium will enable you to:
  • Review the last evidence for DES & DCB.
  • Highlight the importance of Head to Head trials in the day to day practice.
  • Make the right decision for high risk patient and complex lesions.
 
WED 29 - First time data release
10:17 – 10:22 • Main Arena 1
COMPARE-RCT OF LOW DOSE VS. HIGH DOSE PACLITAXEL COATED BALLOONS: 1-YEAR RESULTS OF THE FULL COHORT
Presented by: Dr. Sabine Steiner
10:37 – 10:42 • Main Arena 1
RANGER II SFA: RANDOMIZED TRIAL OF RANGER DCB VS. PTA IN THE SFA
Presented by: Prof. Dr. Marianne Brodmann
16:30 – 16:35 • Main Arena 1
2-YEAR OUTCOMES FROM THE IMPERIAL RANDOMIZED STUDY OF ELUVIA AND ZILVER  PTX
Presented by: Dr. William Gray
Top